HIGHLIGHTS
- who: Lihong Mei et al. from the University of Montenegro, Montenegro Shanghai Jiao Tong University, China have published the Article: Metabolomics profiling in prediction of chemo-immunotherapy efficiency in advanced non-small cell lung cancer, in the Journal: (JOURNAL)
- what: In this study, GC-MS metabolomics was developed to predict the efficiency of chemo-immunotherapy in patients with advanced NSCLC before treatment delivery.
- how: Enrichment and pathway analysis Results showed that urea_cycle glucose-alanine cycle glycine and serine metabolism alanine metabolism and glutamate metabolism were evolved in chemo-immunotherapy response in advanced NSCLC . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.